Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1915.0,1.0,G75V + T76I,75,G75V + T76I,1,=,2492.0,1.0,=,0.8
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1170.0,1.0,G75V + T76I,75,G75V + T76I,1,=,1307.0,1.0,=,0.9
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,672.0,1.0,G75V + T76I,75,G75V + T76I,1,=,488.0,1.0,=,1.4
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,571.0,1.0,G75V + T76I,75,G75V + T76I,1,=,479.0,1.0,=,1.2
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3338.0,1.0,G75V + T76I,75,G75V + T76I,1,=,2958.0,1.0,=,1.1
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3486.0,1.0,G75V + T76I,75,G75V + T76I,1,=,2711.0,1.0,=,1.3
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2294.0,1.0,G75V + T76I,75,G75V + T76I,1,=,2772.0,1.0,=,0.8
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,697.0,1.0,G75V + T76I,75,G75V + T76I,1,=,643.0,1.0,=,1.1
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2572.0,1.0,G75V + T76I,75,G75V + T76I,1,=,2891.0,1.0,=,0.9
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,939.0,1.0,G75V + T76I,75,G75V + T76I,1,=,894.0,1.0,=,1.1
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1445.0,1.0,G75V + T76I,75,G75V + T76I,1,=,1194.0,1.0,=,1.2
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2205.0,1.0,G75V + T76I,75,G75V + T76I,1,=,2103.0,1.0,=,1.0
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1689.0,1.0,G75V + T76I,75,G75V + T76I,1,=,1689.0,1.0,=,1.0
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3189.0,1.0,G75V + T76I,75,G75V + T76I,1,=,2303.0,1.0,=,1.4
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1352.0,1.0,G75V + T76I,75,G75V + T76I,1,=,1149.0,1.0,=,1.2